These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 19249478)
1. C5a inhibitory peptide combined with gabexate mesilate is a clinically available candidate for preventing the instant blood-mediated inflammatory reaction. Tokodai K; Goto M; Imura T; Ogawa N; Fujimori K; Kurokawa Y; Okada H; Satomi S Transplant Proc; 2009; 41(1):67-8. PubMed ID: 19249478 [TBL] [Abstract][Full Text] [Related]
2. C5a-inhibitory peptide combined with gabexate mesilate prevents the instant blood-mediated inflammatory reaction in a rat model of islet transplantation. Tokodai K; Goto M; Inagaki A; Nakanishi W; Okada N; Okada H; Satomi S Transplant Proc; 2010; 42(6):2102-3. PubMed ID: 20692418 [TBL] [Abstract][Full Text] [Related]
3. Effect of synthetic protease inhibitor gabexate mesilate on attenuation of coagulant activity and cytokine release in a rat model of islet transplantation. Tokodai K; Goto M; Inagaki A; Imura T; Satomi S Transplant Proc; 2011 Nov; 43(9):3176-8. PubMed ID: 22099749 [TBL] [Abstract][Full Text] [Related]
4. A precise analysis of C5a inhibitory peptide on inflammatory mediators induced after islet transplantation. Nakanishi W; Goto M; Inagaki A; Sekiguchi S; Fujimori K; Okada N; Okada H; Satomi S Transplant Proc; 2011 Nov; 43(9):3235-8. PubMed ID: 22099765 [TBL] [Abstract][Full Text] [Related]
5. Attenuation of cross-talk between the complement and coagulation cascades by C5a blockade improves early outcomes after intraportal islet transplantation. Tokodai K; Goto M; Inagaki A; Nakanishi W; Ogawa N; Satoh K; Kawagishi N; Sekiguchi S; Nilsson B; Okada N; Okada H; Satomi S Transplantation; 2010 Dec; 90(12):1358-65. PubMed ID: 21197712 [TBL] [Abstract][Full Text] [Related]
6. Hyperoxia improves the survival of intraportally transplanted syngeneic pancreatic islets. Hughes SJ; Davies SE; Powis SH; Press M Transplantation; 2003 Jun; 75(12):1954-9. PubMed ID: 12829893 [TBL] [Abstract][Full Text] [Related]
7. Interference with tissue factor prolongs intrahepatic islet allograft survival in a nonhuman primate marginal mass model. Berman DM; Cabrera O; Kenyon NM; Miller J; Tam SH; Khandekar VS; Picha KM; Soderman AR; Jordan RE; Bugelski PJ; Horninger D; Lark M; Davis JE; Alejandro R; Berggren PO; Zimmerman M; O'Neil JJ; Ricordi C; Kenyon NS Transplantation; 2007 Aug; 84(3):308-15. PubMed ID: 17700154 [TBL] [Abstract][Full Text] [Related]
8. Effect of donor treatment with heparinoids on graft function after intraportal transplantation of a marginal islet mass: an experimental study. Juszczak MT; Hughes SJ; Jones GL; Powis SH; Press M Transplant Proc; 2004 Dec; 36(10):3117-20. PubMed ID: 15686709 [TBL] [Abstract][Full Text] [Related]
9. Prevention of early loss of transplanted islets in the liver of mice by adenosine. Nitta T; Itoh T; Matsuoka N; Mera T; Kojima D; Nakano M; Yamashita Y; Yasunami Y Transplantation; 2009 Jul; 88(1):49-56. PubMed ID: 19584680 [TBL] [Abstract][Full Text] [Related]
11. The effects of gabexate mesilate on the microsurgical reconstruction of the hepatic artery in living donor liver transplantation. Miyagi S; Enomoto Y; Sekiguchi S; Kawagishi N; Satomi S Transplant Proc; 2010 Dec; 42(10):4158-60. PubMed ID: 21168651 [TBL] [Abstract][Full Text] [Related]
12. α-1 Antitrypsin Enhances Islet Engraftment by Suppression of Instant Blood-Mediated Inflammatory Reaction. Wang J; Sun Z; Gou W; Adams DB; Cui W; Morgan KA; Strange C; Wang H Diabetes; 2017 Apr; 66(4):970-980. PubMed ID: 28069642 [TBL] [Abstract][Full Text] [Related]
13. Prospective and randomized study of gabexate mesilate for the treatment of severe acute pancreatitis with organ dysfunction. Chen HM; Chen JC; Hwang TL; Jan YY; Chen MF Hepatogastroenterology; 2000; 47(34):1147-50. PubMed ID: 11020900 [TBL] [Abstract][Full Text] [Related]